26 August 2019 - China's top legislature on Monday voted to adopt the revision to the drug administration law as part of the country's efforts to ensure drug safety and meet people's health demands.

Lawmakers approved the revision at the closing meeting of a five-day bimonthly session of the National People's Congress (NPC) Standing Committee.

Aimed at addressing prominent problems of the pharmaceutical industry, such as counterfeit and substandard drugs and high drug prices, the revised law stipulates the strictest standards and toughest measures in supervision over the whole process of the industry chain.

Read Xinhuanet article